Company / Depreciation & Amortization
MEDICINOVA INC Depreciation & Amortization History
FY2011-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$20.1K
FY2025
5-year range
$17.7K / $26.1K
FY2021-FY2025
Trend
-1.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Increased from $17,707 to $20,099 over the past 2 years.
Based on SEC 10-K filings.
$20,099 in FY2025 with a 3-year CAGR of +4.3%.
Increased from $17,707 to $20,099 over the past 2 years.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- +4.3%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of +4.3%, indicating consistent growth.
- In FY2025, depreciation & amortization decreased 1.0% year-over-year.
- Peak depreciation & amortization was recorded in FY2013.
- Lowest depreciation & amortization in the period was in FY2023.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -4.27 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $20.1K | -1.0% |
| FY2024 | $20.3K | +14.6% |
| FY2023 | $17.7K | +0.0% |
| FY2022 | $17.7K | -32.3% |
| FY2021 | $26.1K | -34.9% |
| FY2014 | $40.2K | -42.2% |
| FY2013 | $69.5K | +66.1% |
| FY2012 | $41.9K | +0.0% |
| FY2011 | $41.9K | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026